会社概要
- 正式社名: India Glycols Limited
- 登録国: India
- 住所: 2b Sector-126, Noida, Uttar Pradesh
- 従業員数: 500 - 999
説明:
This company's key nutraceutical portfolio includes hexane-free extracted lutein and lutein ester (patented in the US, Japan and Europe), zeaxanthin, natural astaxanthin, EP/USP-compliant ginger extract, curcumin (95% and 10% CWS grades), veg DHA and solvent-free coleus. Its Maxicuma is the first green biocurcumin, an instant cold-water-soluble curcumin scientifically proven to be 24 times more bioavailable and taste-neutral, part of its Ennsol range of cold-water-soluble ingredients, alongside a cosmeceutical centella asiatica extract line.
事業活動
賦形剤・添加剤
原薬メーカー
天然抽出物・生薬原料
原薬メーカー
ATC分類(解剖治療化学分類)
原薬メーカー
先発品原薬
原薬メーカー
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
当社の製品・サービス
Sell · Natural Extracts & Herbal Ingredients
Sell · Natural Extracts & Herbal Ingredients
Sell · Natural Extracts & Herbal Ingredients
Sell · Natural Extracts & Herbal Ingredients
Sell · Natural Extracts & Herbal Ingredients
Sell · Natural Extracts & Herbal Ingredients
Sell · Natural Extracts & Herbal Ingredients
Sell · ATC (Anatomical Therapeutic Chemical) Classification
認証
GMP
ISO
証明
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す